Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids.
Cisplatin and doxorubicin were used in the treatment of recurrent invasive basal cell carcinoma (BCC) of the medial canthus and orbit. Complete remission was observed after treatment termination, and this was still evident five years later. Systemic chemotherapy offers an alternative mode of treatment for selected cases of advanced BCC.
Neudorfer
M
M
Department of Ophthalmology, Ichilov Hospital, Tel Aviv, Israel.
Merimsky
O
O
Lazar
M
M
Geyer
O
O
D000368:Aged; D002280:Basal Cell Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005142:Eyelid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009361:Neoplasm Invasiveness; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
D004317:Doxorubicin; D002945:Cisplatin